Serum Uric Acid and Progression of Kidney Disease: A Longitudinal Analysis and Mini-ReviewReportar como inadecuado

Serum Uric Acid and Progression of Kidney Disease: A Longitudinal Analysis and Mini-Review - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.


Increasing evidence supports the association between hyperuricemia and incident chronic kidney disease CKD; however, there are conflicting data regarding the role of hyperuricemia in the progression of CKD. This study retrospectively assessed the longitudinal association between uric acid UA level and CKD progression in a Chinese population lived in Taiwan.


Patients with physician diagnosis of hyperuricemia or receiving urate-lowering therapy between 2003 and 2005 were identified in the electronic medical records EMR of a tertiary medical center and were followed up until December 31, 2011. Patients were divided into four UA categories at the cut-off 6, 8, and 10 mg-dL. CKD progression was estimated by the change of estimated glomerular filtration rate eGFR in the linear mixed models. Kidney failure was defined as an eGFR less than 15 mL-min-1.73 m2 or requiring renal replacement therapy.


A total of 739 patients were analyzed. In the full-adjusted model, patients with a baseline UA level ≥6 mg-dL had greater decline in eGFR β = -9.6, 95% CI -16.1 -3.1, comparing to those with a UA level less than 6 mg-dL. When stratifying patients into four UA categories, all three hyperuricemia categories UA6-8, 8–10, ≥10 mg-dL associated with a greater decline in eGFR over the follow-up period with an increasing dose-response, comparing to the lowest UA category. The risk of progression to renal failure increased 7% hazard ratio 1.07, 95% CI 1.00, 1.14 for each 1mg-dL increase in baseline UA level. The influences of hyperuricemia on eGFR decline and the risk of kidney failure were more prominent in patients without proteinuria than those with proteinuria.


Our study showed a higher uric acid level is associated with a significant rapid decline in eGFR and a higher risk of kidney failure, particularly in patients without proteinuria. Our findings suggest hyperuricemia is a potential modifiable factor of CKD progression.

Autor: Ching-Wei Tsai, Shih-Yi Lin, Chin-Chi Kuo, Chiu-Ching Huang



Documentos relacionados